Klokter Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 05-12-2024
- Paid Up Capital ₹ 0.50 M
as on 05-12-2024
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 27519.40%
(FY 2023)
- Profit -172.92%
(FY 2023)
- Ebitda 763.07%
(FY 2023)
- Net Worth -212.83%
(FY 2023)
- Total Assets 52.87%
(FY 2023)
About Klokter Life Sciences
The Corporate was formerly known as Klokter Life Sciences Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Rajeev Mukul, Dinesh Kakar, and Verinder Chhabra serve as directors at the Company.
- CIN/LLPIN
U24110DL2019PTC357489
- Company No.
357489
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Nov 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Klokter Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeev Mukul  | Director | 15-Nov-2019 | Current |
| Dinesh Kakar | Director | 11-Sep-2020 | Current |
| Verinder Chhabra | Director | 26-May-2023 | Current |
Financial Performance and Corporate Structure Insights of Klokter Life Sciences.
Klokter Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27519.4% increase. The company also saw a substantial fall in profitability, with a 172.92% decrease in profit. The company's net worth observed a substantial decline by a decrease of 212.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Klokter Life Sciences?
In 2023, Klokter Life Sciences had a public holding of 2.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Deventure Hotels Private LimitedActive 16 years 5 monthsRajeev Mukul and Dinesh Kakar are mutual person
Devent Hotel And Services Private LimitedActive 7 years 11 monthsVerinder Chhabra is a mutual person
Deventure Hospitality Private LimitedActive 8 years 7 monthsRajeev Mukul and Verinder Chhabra are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Klokter Life Sciences?
Klokter Life Sciences has a workforce of 35 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Klokter Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Klokter Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
